Zhang Liang, Zhou Jianye, Lu Qingping, Wei Yingjie, Hu Shengshou
Research Center for Cardiovascular Regenerative Medicine, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 Beilishilu, Beijing 100037, PR China.
Biotechnol Bioeng. 2008 Mar 1;99(4):1007-15. doi: 10.1002/bit.21629.
Small-diameter vascular grafts are potential substitutes for damaged vessels in patients, but most biodegradable grafts available now are not strong enough. The present study examined the burst strength, radial compliance, suture retention strength for a novel biodegradable tubular scaffold and investigated its behavior in vivo. The tubular scaffold (6-mm i.d., 4 cm long) has three layers including porous polylacticglycolic- acid in both inner and outer layers, a compact polyurethanes layer in midst. Bone marrow stromal cells (bMSCs) were seeded on the scaffolds and cultured for 7 days in vitro to construct tissue engineered vascular grafts which were then implanted in canine abdominal aorta. After 1, 3, 6, 12 and 24 weeks, the grafts were retrieved and evaluated histologically, angiographically and immunohistochemically. The biodegradable tubular scaffolds showed wall thickness of 0.295 mm to 0.432 mm; radial compliance of 3.80%/100 mmHg approximately 0.57%/100 mmHg, burst strength of 160 kPa approximately 183 kPa, and suture retention strength of 1959 N/cm(2) approximately 3228N/cm(2). The implanted grafts were fully patent without any signs of dilation or obstruction after 3 months' implantation. Scanning electron microscopy revealed a confluence endothelial cell layer spreading on the inner surface of the grafts. Immunohistochemistry of the retrieved grafts showed that vWF-stainin, alphaSMA-staining were positive in the inner and medium layer respectively. Masson's trichrome staining showed that amount of collagen fibers existed in the grafts wall. Overall, these novel three-layered scaffolds exhibited favourable mechanical strength, long term patency and good remodeling in vivo.
小口径血管移植物是患者受损血管的潜在替代品,但目前大多数可生物降解的移植物强度不够。本研究检测了一种新型可生物降解管状支架的爆破强度、径向顺应性、缝线保留强度,并研究了其在体内的行为。该管状支架(内径6mm,长4cm)有三层,内层和外层均为多孔聚乳酸乙醇酸,中间是致密的聚氨酯层。将骨髓基质细胞(bMSCs)接种在支架上,体外培养7天以构建组织工程血管移植物,然后将其植入犬腹主动脉。在1、3、6、12和24周后,取出移植物并进行组织学、血管造影和免疫组织化学评估。可生物降解管状支架的壁厚为0.295mm至0.432mm;径向顺应性为3.80%/100mmHg至0.57%/100mmHg,爆破强度为160kPa至183kPa,缝线保留强度为1959N/cm²至3228N/cm²。植入3个月后,植入的移植物完全通畅,没有任何扩张或阻塞的迹象。扫描电子显微镜显示移植物内表面有汇合的内皮细胞层。取出的移植物免疫组织化学显示,vWF染色、αSMA染色分别在内层和中层呈阳性。Masson三色染色显示移植物壁内存在一定量的胶原纤维。总体而言,这些新型三层支架在体内表现出良好的机械强度、长期通畅性和良好的重塑能力。